Skip to main content
A healthcare professional in a white coat speaks with a patient in a bright clinical setting.

Why Boston Scientific DBS

Choosing a partner for your care is a big decision.
Our Vercise Genus™ DBS System is designed to help your physician personalize therapy from the very beginning—and continue refining it as your needs change over time.

The Boston Scientific difference

Personalized therapy begins with precision. Every person's brain anatomy is unique. That's why we believe personalization starts with placing stimulation in the right location.



Image Guided Programming (IGP) uses your own brain imaging to help your physician identify where stimulation should be delivered, providing a personalized starting point based on your anatomy. From there, your physician can continue refining therapy based on your symptoms, goals, and response over time.



Combined with our advanced directional leads, flexible programming capabilities, and proven clinical outcomes, we provide powerful tools to personalize therapy throughout your DBS journey.

DBS therapy, your way

See if DBS therapy may be right for you

Answer a few quick questions about your PD or ET symptoms. It should take no more than 5 minutes, and you’ll get information on whether our personalized therapy might be right for you.

Get started

Has a physician diagnosed you or a loved one with Parkinson’s disease (PD) or essential tremor (ET)?

Hardware designed for your life

Cartesia X and HX deep brain stimulation leads.

Cartesia™ X and HX Leads

Every brain is different.



Our Cartesia™ X and HX directional leads feature 16 individual contacts, giving physicians exceptional flexibility to direct stimulation exactly where it's needed while avoiding areas that may contribute to side effects.



More contacts mean more opportunities to personalize therapy as your needs evolve.

A group of Boston Scientific VERCISE GENUS implantable devices is displayed against a clean white background.

The broadest battery portfolio

Your therapy should fit your lifestyle.



We offer five battery options, including rechargeable and non-rechargeable systems, so you and your physician can choose the option that best fits your preferences and long-term treatment plan.

Several implantable deep brain stimulation medical devices arranged in front of a tablet and a smartphone.

Multiple Independent Current Control (MICC)

Precision goes beyond where stimulation is delivered.



MICC technology gives each contact its own independent power source, allowing your physician to adjust the size, shape, and location of stimulation with exceptional precision.



This flexibility helps personalize therapy today—and as your needs change over time.

Software that simplifies your care

Explore the intelligent software features that make your programming sessions faster, clearer, and more collaborative.

A 3D medical visualization shows several semi-transparent anatomical structures in different colors against a black background.

Image Guided Programming (IGP)

Personalization starts with your anatomy.



Instead of relying primarily on trial-and-error programming, Image Guided Programming uses your own imaging to help physicians visualize where stimulation should be delivered. They can adjust your therapy, on a screen, in real-time.1

A tablet screen shows a specialized medical software interface for brain stimulation.

Precision with Illumina 3D™

Your physician can see where stimulation is going—not simply where the lead is located.



Illumina 3D software creates a specific stimulation plan using your anatomy, helping personalize therapy with confidence while making precise adjustments over time.



In one study, 88% of patients preferred the program generated with Illumina 3D compared with conventional programming.3

A healthcare professional holds a tablet displaying a detailed 3D medical scan and anatomical diagrams.

Efficient Programming Sessions

Less time adjusting therapy. More time focused on you.



Because Image Guided Programming provides a personalized starting point, programming sessions can be faster while still delivering precise therapy.



Real-world data demonstrated a 72% reduction in initial programming time, with stimulation settings remaining remarkably consistent over time.1

Backed by 5-year clinical data

When choosing a DBS System, you want to know it provides lasting relief. Recent studies tracking patients over 5 years demonstrate that our therapy aims to provide significant, lasting improvements for your movement disorder symptoms.2

94% patient satisfaction

Over a 5-year study, 94% of patients reported feeling satisfied with their DBS therapy.

76% tremor improvement

Patients saw a 76% improvement in their resting tremors 5 years after their procedure.

28% reduction in medications

On average, patients reduced their daily PD medications by 28% over the entire 5-year study.

70% decrease in dyskinesia

The study showed a 70% decrease in involuntary movements after 5 years.

See our technology in action

What’s Image Guided Programming?

Your anatomy provides a roadmap for personalized therapy. Learn how Image Guided Programming helps physicians visualize stimulation, personalize therapy from the beginning, and continue refining treatment as your needs evolve.

REAL SUCCESS STORIES

Ken's DBS story

“With DBS, it's become easier. It's amazing they can do this — the awe of the performance and the technology, what can be pulled off — it seems like there's a lot more hope in my life and I feel generally really good.”


The patient quotes in this material describe real personal experiences. Individual results may vary. Consult with your physician to determine if you are a candidate for this procedure and what you may gain from the therapy.

More PD successes
More ET successes
A professional woman stands behind a lectern giving a presentation with a laptop open in front of her.

Create connections that matter

From local in-person gatherings to expert-led webinars, connect with those who know DBS and those who live with it to share experiences, gain knowledge, and find support.

Explore events

Have questions about DBS?

Get answers to common questions about DBS, from the procedure to recovery and beyond.

Explore our DBS FAQs

Take your next step toward DBS therapy

DBS therapy, your way

See if DBS therapy may be right for you

Answer a few quick questions about your PD or ET symptoms. It should take no more than 5 minutes, and you’ll get information on whether our personalized therapy might be right for you.

Get started

Has a physician diagnosed you or a loved one with Parkinson’s disease (PD) or essential tremor (ET)?

A person holds a smartphone while relaxing indoors with a mug in the other hand. The phone screen displays a website titled "Find a DBS specialist near you" with a search interface and a map.

Find Care

Locate a DBS specialist near you

Find a movement disorder specialist who offers Boston Scientific’s personalized DBS therapy near you.

A person with long wavy hair wears an over-ear headset while seated at an office workstation.

questions?

Call Patient Education

Our Patient Education Specialists can give guidance and answer any questions you have during your search for the right DBS System.

Call us at (833) 327-1473

Monday through Friday

7 a.m. to 4:30 p.m. PT

References  

  1. Aldred et al. (2023). Image-Guided Programming Tool for DBS Programming Reduces Initial DBS Programming Time and Allows for Sustained Settings Long-Term. MDS 2023 Poster. ​ 
  2. Starr PA et al. Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson Disease. JAMA Neurol. 2024. 
  3. M. Ferris, J. Kim, B. Reid, V. Buch. Outcomes of Algorithm Guided DBS Programming: A case series [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/outcomes-of-algorithm-guided-dbs-programming-a-case-series/. Accessed October 28, 2025.

Indications for Use:
The Boston Scientific Vercise™ PC, Vercise Gevia™, Vercise Genus™ Deep Brain Stimulation (DBS) Systems are indicated for use in the following:

• Bilateral stimulation of the subthalamic nucleus (STN) as an adjunctive therapy in reducing some of the symptoms of moderate to advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.

• Bilateral stimulation of the internal globus pallidus (GPi) as an adjunctive therapy in reducing some of the symptoms of advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.

• Unilateral thalamic stimulation of the ventral intermediate nucleus (VIM) is indicated for the suppression of tremor in the upper extremity. The system is intended for use in patients who are diagnosed with essential tremor or parkinsonian tremor not adequately controlled by medications and where the tremor constitutes a significant functional disability.

• Bilateral stimulation of the ventral intermediate nucleus (VIM) of the thalamus for the suppression of disabling upper extremity tremor in adult essential tremor patients whose tremor is not adequately controlled by medications and where the tremor constitutes a significant functional disability.

Intended Use:

The Boston Scientific Deep Brain Stimulation (DBS) Systems are intended to treat movement disorders by stimulating a specific brain target.

The Vercise™ DBS Controller is intended to communicate with and control the compatible Boston Scientific Stimulator.

The Charger is a medical device that is intended to charge the battery of the compatible Boston Scientific rechargeable Stimulator.

Contraindications: The Boston Scientific Deep Brain Stimulation (DBS) Systems are not recommended for patients who will be exposed to the following procedures: Diathermy as either a treatment for a medical condition or as part of a surgical procedure, Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS). The safety of these therapies in patients implanted with the Boston Scientific DBS System has not been established. Patients implanted with Boston Scientific DBS Systems without ImageReady™ MRI Technology should not be exposed to Magnetic Resonance Imaging (MRI). Patients implanted with the Vercise Gevia or Vercise Genus or Vercise Genus Mixed System with M8 Adapter or Vercise DBS Lead-Only System (before Stimulator is implanted) with ImageReady MRI Technology are Full Body MR Conditional only when exposed to the MRI environment under the specific conditions defined in ImageReady MRI Guidelines for Boston Scientific DBS Systems. The external/non-implantable components of the Vercise Genus DBS System (Charging System, Remote Control, mobile device with Vercise DBS Controller, and accessories) are MR Unsafe. Do not take them into any MRI environment.
Boston Scientific DBS Systems are not recommended for patients who are unable to operate the system or are poor surgical candidates or who experience unsuccessful test stimulation.

Warnings: With all medical procedures, there are risks associated with the procedure and the use of the device. Unauthorized modification to the medical devices is prohibited. You should not be exposed to high stimulation levels. High level of stimulation may damage brain tissue. Patients implanted with a Boston Scientific DBS System may be at risk for intracranial hemorrhages (bleeding in the brain) during DBS lead placement. Strong electromagnetic fields, such as power generators, security screeners or theft detection systems, can potentially turn the stimulator off, or cause unpredictable changes in stimulation. The system should not be charged while sleeping. If you notice new onset or worsening depression, changes in mood or behavior or impulse control, or have thoughts of suicide contact your physician or emergency services immediately. You should use caution when doing activities that require coordination, even if you were able to do them before receiving therapy (for example, swimming). Patients should exercise reasonable caution when bathing. Chemical burns may result if the Stimulator housing is ruptured or pierced. The Boston Scientific DBS Systems may interfere with the operation of implanted stimulation devices, such as cardiac pacemakers, implanted cardioverter defibrillators, or medication delivery pumps. Patients should operate motorized vehicles or potentially dangerous machinery with caution. It is unknown whether the DBS device may cause complications with pregnancy. Do not use the Vercise™ DBS Controller while the mobile device is charging. The effect of using the Vercise DBS Controller while charging the mobile device has not been evaluated.



Be sure to talk with your doctor so that you thoroughly understand all of the risks, precautions, and benefits associated with the use of the device and what indicates, and contraindicates, certain patients– as well as the risks and precautions for the procedure. For complete indications for use, contraindications, warnings, precautions, and side effects, see DBSandME.com or call 833-DBS-INFO or 833-327-4636.



CAUTION: U.S. Federal law  restricts this device to sale by or on the order of a physician.

NM-2199105-AB